ATLAS fair value
SEK 142.77
Above fair value · 126% premium
Bonesupport stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · Nasdaq Stockholm · Sweden
Prices as of Oct 27, 2026 · SEK
SEK 142.77
Above fair value · 126% premium
48%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Bonesupport's fair value at about SEK 142.77 per share (reasonable range: SEK 110.26 to SEK 183.03). At SEK 323.00, the stock trades 126% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Bonesupport a 48% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 292.27 and SEK 352.38; in 9 out of 10, between SEK 247.62 and SEK 415.93. Estimated annual volatility is 56%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Bonesupport sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks BONEX.ST has traded between SEK 165.00 and SEK 340.20. Today it is 5.1% below that high and 96% above its low.
On the business: net margin is 19.4%; it trades at 101.2 times earnings.
Its beta is 0.31: it tends to move less than the market.
Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
Want to see everything about Bonesupport?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About SEK 142.77 per share according to ATLAS (reasonable range: SEK 110.26 to SEK 183.03). With the stock at SEK 323.00, it is 126% above it.
48%: close to a coin flip. In half of the simulated outcomes, BONEX.ST ends the month between SEK 292.27 and SEK 352.38.
Bonesupport's market capitalization is SEK 16.6B. Its price-to-earnings (P/E) ratio is 101.2: you pay SEK 101.2 for each SEK 1.00 of yearly earnings.
ATLAS estimates annual volatility at 56%. In a typical month, half of the outcomes end between SEK 292.27 and SEK 352.38.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy